EQRX wants to make high-end medicines less costly

A BIOTECH STARTUP wants to make me-too versions of existing drugs. So far, so familiar. Except that EQRx, a firm based in Boston, aims to launch ten high-end ... Read more

Bron:

The Economist: Business